BackProMIS Neurosciences Overview
ProMIS Neurosciences Inc.

ProMIS Neurosciences Target Price

See ProMIS Neurosciences's analyst price targets ($24) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.79

Average Target Price

$24.0062.3% upside

3 analysts in the last 4 months

High: $33 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28Chardan CapitalKeay Nakae$33123.1% upsideOpen
2026-07-27Chardan CapitalKeay Nakae$2035.2% upsideOpen
2026-07-07Roth Capital$1928.5% upsideOpen
2025-12-01H.C. Wainwright$1821.7% upsideOpen
2025-07-14H.C. WainwrightRaghuram Selvaraju$100576.1% upsideOpen

ProMIS Neurosciences (PMN) FAQ

The latest target price for PMN is $24. Investors often review this figure alongside ProMIS Neurosciences's historical trend and sector peers before judging valuation or financial health.

ProMIS Neurosciences trades near $14.79 while the consensus target sits at $24 (62.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting PMN's target price ($24), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack ProMIS Neurosciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.